PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway

Zeng,Min; Xu,Minjuan; Li,Xiafang; Li,Junying; Liu,Yuanyuan

doi:10.3892/etm.2022.11505

PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway

Authors:
- Min Zeng
- Minjuan Xu
- Xiafang Li
- Junying Li
- Yuanyuan Liu
View Affiliations

Affiliations: Department of Obstetrics, Ganzhou People's Hospital, Ganzhou, Jiangxi 341001, P.R. China
Published online on: July 12, 2022 https://doi.org/10.3892/etm.2022.11505
Article Number: 568
Copyright: © Zeng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Preeclampsia (PE), presenting with onset hypertension and proteinuria, is a pregnancy‑specific disorder that can result in maternal and fetal morbidity and mortality. Insufficient trophoblast invasion and migration has been considered to be an important cause of this disease. The present study aimed to investigate the role of peptidyl arginine deiminase 4 (PAD4), whose knockdown has been previously indicated to reduce inflammation and susceptibility to pregnancy loss in mice, in the development of PE in vitro. Lipopolysaccharide (LPS) was used to treat a human trophoblast cell line (HTR8/SVneo). After PAD4 silencing via transfection with short hairpin RNA against PAD4, the concentrations of inflammatory factors IL‑6, IL‑12 and monocyte chemoattractant protein (MCP)‑1 were measured using ELISA. Cell viability was also measured using Cell Counting Kit‑8 assay. HTR8/SVneo cell invasion and migration were detected using Transwell and wound healing assays, respectively. Western blotting was used to measure the expression of citrullinated NF‑κB essential modulator (NEMO) and nuclear NF‑κB p65 protein levels. TNF‑α was applied for evaluating the potential regulatory effects of PAD4 on NF‑κB in LPS‑stimulated HTR8/SVneo cells. LPS increased the levels of IL‑6, IL‑12 and MCP‑1 and reduced the migration and invasion of HTR8/SVneo cells. PAD4‑knockdown was found to markedly reduce the levels of IL‑6, IL‑12 and MCP‑1 secretion. HTR8/SVneo cell invasion and migration was also significantly elevated after PAD4 silencing following LPS exposure. In addition, LPS stimulation notably upregulated the protein levels of citrullinated NEMO and nuclear NF‑κB p65, which was restored by PAD4 knockdown. Furthermore, TNF‑α treatment partially counteracted the effects of PAD4 knockdown on the secretion of IL‑6, MCP‑1 and IL‑12, which are markers of inflammation, and invasion and migration in LPS‑induced HTR8/SVneo cells. To conclude, these results suggest that PAD4 silencing can suppress inflammation whilst promoting invasion and migration by trophoblast cells through inhibiting the NEMO/NF‑κB pathway. These findings furthered the understanding in the complex molecular mechanism that can trigger PE and provide a promising target for the treatment of this disease.

View Figures

View References

1	Capriglione S, Plotti F, Terranova C, Gulino FA, Di Guardo F, Lopez S, Scaletta G and Angioli R: Preeclampsia and the challenge of early prediction: Reality or utopia? State of art and critical review of literature. J Matern Fetal Neonatal Med. 33:677–686. 2020.PubMed/NCBI View Article : Google Scholar
2	Mazzuca MQ, Li W, Reslan OM, Yu P, Mata KM and Khalil RA: Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy. Hypertension. 64:632–643. 2014.PubMed/NCBI View Article : Google Scholar
3	Li X, Wu C, Shen Y, Wang K, Tang L, Zhou M, Yang M, Pan T, Liu X and Xu W: Ten-eleven translocation 2 demethylates the MMP9 promoter, and its down-regulation in preeclampsia impairs trophoblast migration and invasion. J Biol Chem. 293:10059–10070. 2018.PubMed/NCBI View Article : Google Scholar
4	Xie N, Jia Z and Li L: miR-320a upregulation contributes to the development of preeclampsia by inhibiting the growth and invasion of trophoblast cells by targeting interleukin 4. Mol Med Rep. 20:3256–3264. 2019.PubMed/NCBI View Article : Google Scholar
5	Rohrbach AS, Slade DJ, Thompson PR and Mowen KA: Activation of PAD4 in NET formation. Front Immunol. 3(360)2012.PubMed/NCBI View Article : Google Scholar
6	Wang S and Wang Y: Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. Biochim Biophys Acta. 1829:1126–1135. 2013.PubMed/NCBI View Article : Google Scholar
7	Erpenbeck L, Chowdhury CS, Zsengellér ZK, Gallant M, Burke SD, Cifuni S, Hahn S, Wagner DD and Karumanchi SA: PAD4 deficiency decreases inflammation and susceptibility to pregnancy loss in a mouse model. Biol Reprod. 95(132)2016.PubMed/NCBI View Article : Google Scholar
8	Rabadi M, Kim M, D'Agati V and Lee HT: Peptidyl arginine deiminase-4-deficient mice are protected against kidney and liver injury after renal ischemia and reperfusion. Am J Physiol Renal Physiol. 311:F437–F449. 2016.PubMed/NCBI View Article : Google Scholar
9	Rabadi MM, Han SJ, Kim M, D'Agati V and Lee HT: Peptidyl arginine deiminase-4 exacerbates ischemic AKI by finding NEMO. Am J Physiol Renal Physiol. 316:F1180–F1190. 2019.PubMed/NCBI View Article : Google Scholar
10	Vaughan JE and Walsh SW: Activation of NF-κB in placentas of women with preeclampsia. Hypertens Pregnancy. 31:243–251. 2012.PubMed/NCBI View Article : Google Scholar
11	Sakowicz A, Lisowska M, Biesiada L, Płuciennik E, Gach A, Rybak-Krzyszkowska M, Huras H, Sakowicz B, Romanowicz H, Piastowska-Ciesielska AW, et al: Placental expression of NEMO protein in normal pregnancy and preeclampsia. Dis Markers. 2019(8418379)2019.PubMed/NCBI View Article : Google Scholar
12	Sakowicz A, Hejduk P, Pietrucha T, Nowakowska M, Płuciennik E, Pospiech K, Gach A, Rybak-Krzyszkowska M, Sakowicz B, Kaminski M, et al: Finding NEMO in preeclampsia. Am J Obstet Gynecol. 214:538.e1–538.e7. 2016.PubMed/NCBI View Article : Google Scholar
13	Sakowicz A, Pietrucha T, Rybak-Krzyszkowska M, Huras H, Gach A, Sakowicz B, Banaszczyk M, Grzesiak M and Biesiada L: Double hit of NEMO gene in preeclampsia. PLoS One. 12(e0180065)2017.PubMed/NCBI View Article : Google Scholar
14	Hu J, Zhang J and Zhu B: Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia. Fundam Clin Pharmacol. 33:649–658. 2019.PubMed/NCBI View Article : Google Scholar
15	Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N and Lala PK: Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res. 206:204–211. 1993.PubMed/NCBI View Article : Google Scholar
16	Abou-Kheir W, Barrak J, Hadadeh O and Daoud G: HTR-8/SVneo cell line contains a mixed population of cells. Placenta. 50:1–7. 2017.PubMed/NCBI View Article : Google Scholar
17	Fan M, Li X, Gao X, Dong L, Xin G, Chen L, Qiu J and Xu Y: LPS induces preeclampsia-like phenotype in rats and HTR8/SVneo cells dysfunction through TLR4/p38 MAPK pathway. Front Physiol. 10(1030)2019.PubMed/NCBI View Article : Google Scholar
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
19	Jena MK, Sharma NR, Petitt M, Maulik D and Nayak NR: Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules. 10(953)2020.PubMed/NCBI View Article : Google Scholar
20	Calicchio R, Buffat C, Vaiman D and Miralles F: Endothelial dysfunction: Role in the maternal syndrome of preeclampsia and long-term consequences for the cardiovascular system. Ann Cardiol Angeiol (Paris). 62:215–220. 2013.PubMed/NCBI View Article : Google Scholar : (In French).
21	Pauli JM and Repke JT: Preeclampsia: Short-term and long-term implications. Obstet Gynecol Clin North Am. 42:299–313. 2015.PubMed/NCBI View Article : Google Scholar
22	Dai X and Cai Y: Down-regulation of microRNA let-7d inhibits the proliferation and invasion of trophoblast cells in preeclampsia. J Cell Biochem. 119:1141–1151. 2018.PubMed/NCBI View Article : Google Scholar
23	Shaw J, Tang Z, Schneider H, Saljé K, Hansson SR and Guller S: Inflammatory processes are specifically enhanced in endothelial cells by placental-derived TNF-α: Implications in preeclampsia (PE). Placenta. 43:1–8. 2016.PubMed/NCBI View Article : Google Scholar
24	Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW Jr, Wallace K and LaMarca B: The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond). 130:409–419. 2016.PubMed/NCBI View Article : Google Scholar
25	Cotechini T, Komisarenko M, Sperou A, Macdonald-Goodfellow S, Adams MA and Graham CH: Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med. 211:165–179. 2014.PubMed/NCBI View Article : Google Scholar
26	Kadam L, Kilburn B, Baczyk D, Kohan-Ghadr HR, Kingdom J and Drewlo S: Rosiglitazone blocks first trimester in-vitro placental injury caused by NF-κB-mediated inflammation. Sci Rep. 9(2018)2019.PubMed/NCBI View Article : Google Scholar
27	Zaga-Clavellina V, Garcia-Lopez G, Flores-Herrera H, Espejel-Nuñez A, Flores-Pliego A, Soriano-Becerril D, Maida-Claros R, Merchant-Larios H and Vadillo-Ortega F: In vitro secretion profiles of interleukin (IL)-1beta, IL-6, IL-8, IL-10, and TNF alpha after selective infection with Escherichia coli in human fetal membranes. Reprod Biol Endocrinol. 5(46)2007.PubMed/NCBI View Article : Google Scholar
28	Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, van den Berg WB, van Venrooij WJ and Joosten LA: Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum. 48:2489–2500. 2003.PubMed/NCBI View Article : Google Scholar
29	Shelef MA, Sokolove J, Lahey LJ, Wagner CA, Sackmann EK, Warner TF, Wang Y, Beebe DJ, Robinson WH and Huttenlocher A: Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis. Arthritis Rheumatol. 66:1482–1491. 2014.PubMed/NCBI View Article : Google Scholar
30	Li H, Han SJ, Kim M, Cho A, Choi Y, D'Agati V and Lee HT: Divergent roles for kidney proximal tubule and granulocyte PAD4 in ischemic AKI. Am J Physiol Renal Physiol. 314:F809–F819. 2018.PubMed/NCBI View Article : Google Scholar
31	Lorquet S, Pequeux C, Munaut C and Foidart JM: Aetiology and physiopathology of preeclampsia and related forms. Acta Clin Belg. 65:237–241. 2010.PubMed/NCBI View Article : Google Scholar
32	Martin E, Ray PD, Smeester L, Grace MR, Boggess K and Fry RC: Epigenetics and preeclampsia: Defining functional epimutations in the preeclamptic placenta related to the TGF-β pathway. PLoS One. 10(e0141294)2015.PubMed/NCBI View Article : Google Scholar
33	Walker JJ: Pre-eclampsia. Lancet. 356:1260–1265. 2000.PubMed/NCBI View Article : Google Scholar
34	Jiang Y and Chen Y and Chen Y: Knockdown of JARID2 inhibits the viability and migration of placenta trophoblast cells in preeclampsia. Mol Med Rep. 16:3594–3599. 2017.PubMed/NCBI View Article : Google Scholar
35	Chen D, Yu M, Chen H, Zeng M, Sun Y and Huang Q: Identification and functional characterization of NEMO in Crassostrea gigas reveals its crucial role in the NF-κB activation. Fish Shellfish Immunol. 80:46–55. 2018.PubMed/NCBI View Article : Google Scholar
36	Ali Z, Zafar U, Khaliq S and Lone KP: Elevated tumor necrosis factor (TNF)-α mRNA expression correlates with nuclear factor kappa B expression in peripheral blood mononuclear cells in preeclampsia. J Coll Physicians Surg Pak. 30:158–162. 2020.PubMed/NCBI View Article : Google Scholar